Attenuated PDGF signaling drives alveolar and microvascular defects in neonatal chronic lung disease.

Attenuated PDGF signaling drives alveolar and microvascular defects in neonatal chronic lung disease.

EMBO molecular medicine (2017-09-20)

Prajakta Oak, Tina Pritzke, Isabella Thiel, Markus Koschlig, Daphne S Mous, Anita Windhorst, Noopur Jain, Oliver Eickelberg, Kai Foerster, Andreas Schulze, Wolfgang Goepel, Tobias Reicherzer, Harald Ehrhardt, Robbert J Rottier, Peter Ahnert, Ludwig Gortner, Tushar J Desai, Anne Hilgendorff

PMID28923828

RÉSUMÉ

Neonatal chronic lung disease (nCLD) affects a significant number of neonates receiving mechanical ventilation with oxygen-rich gas (MV-O

MATÉRIAUX

Référence du produit

Marque

Description du produit

G1393

Sigma-Aldrich

Gélatine solution, Type B, 2% in H2O, tissue culture grade, BioReagent, suitable for cell culture